{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:09:06Z","timestamp":1782238146628,"version":"3.54.5"},"reference-count":144,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Int"],"DOI":"10.3892\/mi.2025.276","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:10:09Z","timestamp":1761120609000},"page":"1-9","source":"Crossref","is-referenced-by-count":1,"title":["Growth hormone in disease and treatment (Review)"],"prefix":"10.3892","volume":"5","author":[{"given":"Saikat","family":"Fakir","sequence":"first","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Matiur Rahman","family":"Sarker","sequence":"additional","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan","family":"Sigdel","sequence":"additional","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nektarios","family":"Barabutis","sequence":"additional","affiliation":[{"name":"School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA 71201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"2712","key":"key20251124134831_b1-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102712","article-title":"Vascular endothelial cells: Heterogeneity and targeting approaches","volume":"10","author":"Hennigs","year":"2021","journal-title":"Cells"},{"issue":"96","key":"key20251124134831_b2-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-023-00582-8","article-title":"Capillary leak and endothelial permeability in critically ill patients: A current overview","volume":"11","author":"Saravi","year":"2023","journal-title":"Intensive Care Med Exp"},{"key":"key20251124134831_b3-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/00005344-199322004-00002","article-title":"The role of endothelium in cardiovascular homeostasis and diseases","volume":"22 (Suppl 4)","author":"Rubanyi","year":"1993","journal-title":"J Cardiovasc Pharmacol"},{"issue":"365","key":"key20251124134831_b4-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00365","article-title":"Endothelial barrier and its abnormalities in cardiovascular disease","volume":"6","author":"Chistiakov","year":"2015","journal-title":"Front Physiol"},{"issue":"13337","key":"key20251124134831_b5-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413337","article-title":"Immune and metabolic mechanisms of endothelial dysfunction","volume":"25","author":"Kopaliani","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8793","key":"key20251124134831_b6-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228793","article-title":"Endothelial damage in acute respiratory distress syndrome","volume":"21","author":"Vassiliou","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20251124134831_b7-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.5301\/EJO.2010.6049","article-title":"Blood-retinal barrier","volume":"21 (Suppl 6)","author":"Cunha-Vaz","year":"2011","journal-title":"Eur J Ophthalmol"},{"issue":"86","key":"key20251124134831_b8-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1186\/s12987-022-00386-0","article-title":"Transgenic animal models to explore and modulate the blood brain and blood retinal barriers of the CNS","volume":"19","author":"Goncalves","year":"2022","journal-title":"Fluids Barriers CNS"},{"issue":"24","key":"key20251124134831_b9-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-021-00246-2","article-title":"Genetic mutations and molecular mechanisms of Fuchs endothelial corneal dystrophy","volume":"8","author":"Liu","year":"2021","journal-title":"Eye Vis (Lond)"},{"issue":"e651","key":"key20251124134831_b10-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.651","article-title":"Endothelial dysfunction: Molecular mechanisms and clinical implications","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"key":"key20251124134831_b11-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.2337\/dc14-1741","article-title":"Role of endothelial dysfunction and arterial stiffness in the development of diabetic retinopathy","volume":"38","author":"Siasos","year":"2015","journal-title":"Diabetes Care"},{"key":"key20251124134831_b12-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.3390\/ijms150711324","article-title":"Endothelial dysfunction in chronic inflammatory diseases","volume":"15","author":"Steyers","year":"2014","journal-title":"Int J Mol Sci"},{"key":"key20251124134831_b13-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1177\/0003319720987752","article-title":"Endothelial dysfunction and its clinical implications","volume":"72","author":"Poredos","year":"2021","journal-title":"Angiology"},{"issue":"e985954","key":"key20251124134831_b14-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.4161\/21688370.2014.985954","article-title":"Control of vascular permeability by adhesion molecules","volume":"3","author":"Sarelius","year":"2015","journal-title":"Tissue Barriers"},{"key":"key20251124134831_b15-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/j.1538-7836.2008.03087.x","article-title":"Endothelial cell junctions and the regulation of vascular permeability and leukocyte transmigration","volume":"6","author":"Aghajanian","year":"2008","journal-title":"J Thromb Haemost"},{"key":"key20251124134831_b16-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1161\/ATVBAHA.119.312580","article-title":"Endothelial response to pathophysiological stress","volume":"39","author":"Peng","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20251124134831_b17-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"key":"key20251124134831_b18-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00281-011-0285-5","article-title":"Endothelium-role in regulation of coagulation and inflammation","volume":"34","author":"van Hinsbergh","year":"2012","journal-title":"Semin Immunopathol"},{"key":"key20251124134831_b19-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol Rev"},{"issue":"105","key":"key20251124134831_b20-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2703105","article-title":"Oxidative stress-induced endothelial dysfunction in cardiovascular diseases","volume":"27","author":"Shaito","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"21","key":"key20251124134831_b21-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-023-00423-2","article-title":"Endothelial dysfunction due to eNOS uncoupling: molecular mechanisms as potential therapeutic targets","volume":"28","author":"Janaszak-Jasiecka","year":"2023","journal-title":"Cell Mol Biol Lett"},{"key":"key20251124134831_b22-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1161\/01.ATV.0000110785.96039.f6","article-title":"Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease","volume":"24","author":"Alp","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20251124134831_b23-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/JBM.S7000","article-title":"Vascular nitric oxide: Formation and function","volume":"2010","author":"Jin","year":"2010","journal-title":"J Blood Med"},{"key":"key20251124134831_b24-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4330\/wjc.v7.i11.719","article-title":"Vascular endothelial dysfunction and pharmacological treatment","volume":"7","author":"Su","year":"2015","journal-title":"World J Cardiol"},{"key":"key20251124134831_b25-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"9953","DOI":"10.2147\/JIR.S479926","article-title":"Sepsis-induced endothelial dysfunction: Permeability and regulated cell death","volume":"17","author":"Zhang","year":"2024","journal-title":"J Inflamm Res"},{"issue":"e42","key":"key20251124134831_b26-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.15190\/d.2015.34","article-title":"Inflammation between defense and disease: Impact on tissue repair and chronic sickness","volume":"3","author":"Liehn","year":"2015","journal-title":"Discoveries (Craiova)"},{"issue":"100347","key":"key20251124134831_b27-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2025.100347","article-title":"Unveiling the link between chronic inflammation and cancer","volume":"25","author":"Tripathi","year":"2025","journal-title":"Metabol Open"},{"issue":"1906","key":"key20251124134831_b28-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/cells13221906","article-title":"Inflammation: The cause of all diseases","volume":"13","author":"Chavda","year":"2024","journal-title":"Cells"},{"key":"key20251124134831_b29-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"key20251124134831_b30-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"key20251124134831_b31-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"81","DOI":"10.14336\/AD.2015.0803","article-title":"Chronic inflammatory diseases and endothelial dysfunction","volume":"7","author":"Castellon","year":"2016","journal-title":"Aging Dis"},{"issue":"3298","key":"key20251124134831_b32-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39023-1","article-title":"Growth hormone releasing hormone signaling promotes Th17 cell differentiation and autoimmune inflammation","volume":"14","author":"Du","year":"2023","journal-title":"Nat Commun"},{"issue":"1708","key":"key20251124134831_b33-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26041708","article-title":"The interplay between immunity, inflammation and endothelial dysfunction","volume":"26","author":"Chee","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"111455","key":"key20251124134831_b34-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111455","article-title":"Octreotide protects against LPS-induced endothelial cell and lung injury","volume":"124","author":"Fakir","year":"2024","journal-title":"Cell Signal"},{"issue":"e70306","key":"key20251124134831_b35-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70306","article-title":"Pasireotide exerts anti-inflammatory effects in the endothelium","volume":"39","author":"Fakir","year":"2025","journal-title":"J Biochem Mol Toxicol"},{"key":"key20251124134831_b36-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/s0026-0495(99)90261-5","article-title":"Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus","volume":"48","author":"Clemens","year":"1999","journal-title":"Metabolism"},{"issue":"104651","key":"key20251124134831_b37-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2023.104651","article-title":"Involvement of NEK2 and NEK9 in LPS-induced endothelial barrier dysfunction","volume":"152","author":"Barabutis","year":"2024","journal-title":"Microvasc Res"},{"key":"key20251124134831_b38-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1172\/JCI117193","article-title":"Somatostatin analogues suppress the inflammatory reaction in vivo","volume":"93","author":"Karalis","year":"1994","journal-title":"J Clin Invest"},{"key":"key20251124134831_b39-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.exer.2004.06.007","article-title":"Somatostatin inhibits IGF-1 mediated induction of VEGF in human retinal pigment epithelial cells","volume":"79","author":"Sall","year":"2004","journal-title":"Exp Eye Res"},{"key":"key20251124134831_b40-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.bcp.2013.06.001","article-title":"Somatostatin preserved blood brain barrier against cytokine induced alterations: Possible role in multiple sclerosis","volume":"86","author":"Basivireddy","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"key20251124134831_b41-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/ijc.1223","article-title":"Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells","volume":"92","author":"Mentlein","year":"2001","journal-title":"Int J Cancer"},{"key":"key20251124134831_b42-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/pgmj.2005.036087","article-title":"Growth hormone and its disorders","volume":"82","author":"Ayuk","year":"2006","journal-title":"Postgrad Med J"},{"issue":"720419","key":"key20251124134831_b43-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.720419","article-title":"Short and long-term effects of growth hormone in children and adolescents with GH deficiency","volume":"12","author":"Ranke","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"111038","key":"key20251124134831_b44-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111038","article-title":"Effect of growth hormone on insulin signaling","volume":"518","author":"Sharma","year":"2020","journal-title":"Mol Cell Endocrinol"},{"issue":"1436","key":"key20251124134831_b45-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041436","article-title":"Thyrotropin-releasing hormone (TRH) and somatostatin (SST), but not growth hormone-releasing hormone (GHRH) nor Ghrelin (GHRL), regulate expression and release of immune growth hormone (GH) from chicken bursal B-lymphocyte cultures","volume":"21","author":"Pech-Pool","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"35","key":"key20251124134831_b46-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00035","article-title":"The growth hormone receptor: Mechanism of receptor activation, cell signaling, and physiological aspects","volume":"9","author":"Dehkhoda","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20251124134831_b47-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1210\/er.2009-0010","article-title":"The role of liver-derived insulin-like growth factor-I","volume":"30","author":"Ohlsson","year":"2009","journal-title":"Endocr Rev"},{"key":"key20251124134831_b48-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41574-019-0280-9","article-title":"The effects of growth hormone on adipose tissue: Old observations, new mechanisms","volume":"16","author":"Kopchick","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"key20251124134831_b49-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"145","DOI":"10.6065\/apem.2017.22.3.145","article-title":"Effects of growth hormone on glucose metabolism and insulin resistance in human","volume":"22","author":"Kim","year":"2017","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"key20251124134831_b50-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"E1326","DOI":"10.1152\/ajpendo.2001.281.6.E1326","article-title":"Effects of growth hormone on renal tubular handling of sodium in healthy humans","volume":"281","author":"Hansen","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"680579","key":"key20251124134831_b51-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.680579","article-title":"GH replacement in the elderly: Is it worth it?","volume":"12","author":"Ricci Bitti","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"64","key":"key20251124134831_b52-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00064","article-title":"Adult growth hormone deficiency-benefits, side effects, and risks of growth hormone replacement","volume":"4","author":"Reed","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20251124134831_b53-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3803\/EnM.2020.35.2.272","article-title":"Diagnosis and treatment of growth hormone deficiency: A position statement from Korean endocrine society and Korean Society of pediatric endocrinology","volume":"35","author":"Kim","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"key":"key20251124134831_b54-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1210\/er.2013-1067","article-title":"Isolated growth hormone deficiency (GHD) in childhood and adolescence: Recent advances","volume":"35","author":"Alatzoglou","year":"2014","journal-title":"Endocr Rev"},{"key":"key20251124134831_b55-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4274\/jcrpe.v2i2.52","article-title":"Genetics of isolated growth hormone deficiency","volume":"2","author":"Mullis","year":"2010","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"key20251124134831_b56-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4274\/jcrpe.galenos.2019.2018.0305","article-title":"Isolated growth hormone deficiency type 2 due to a novel GH1 mutation: A case report","volume":"11","author":"Kautsar","year":"2019","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"key20251124134831_b57-MI-5-6-00276","first-page":"347","article-title":"Autosomal dominant growth hormone deficiency (type II)","volume":"12","author":"Alatzoglou","year":"2015","journal-title":"Pediatr Endocrinol Rev"},{"key":"key20251124134831_b58-MI-5-6-00276","author":"Feldt-Rasmussen"},{"key":"key20251124134831_b59-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.coph.2003.07.008","article-title":"Adult growth hormone replacement: Current understanding","volume":"3","author":"Murray","year":"2003","journal-title":"Curr Opin Pharmacol"},{"key":"key20251124134831_b60-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"217","DOI":"10.14310\/horm.2002.11103","article-title":"GH deficiency in adults","volume":"2","author":"Papadogias","year":"2003","journal-title":"Hormones (Athens)"},{"key":"key20251124134831_b61-MI-5-6-00276","author":"Bello"},{"key":"key20251124134831_b62-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"96","DOI":"10.6065\/apem.2014.19.2.96","article-title":"Gigantism caused by growth hormone secreting pituitary adenoma","volume":"19","author":"Rhee","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"key20251124134831_b63-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ghir.2016.08.002","article-title":"Genetics of gigantism and acromegaly","volume":"30-31","author":"Hannah-Shmouni","year":"2016","journal-title":"Growth Horm IGF Res"},{"key":"key20251124134831_b64-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11154-025-09951-y","article-title":"Hypothalamic GHRH","volume":"26","author":"Dieguez","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"key20251124134831_b65-MI-5-6-00276","author":"George"},{"issue":"e250076","key":"key20251124134831_b66-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2025-0076","article-title":"Clinical and economic burden among older adults with acromegaly in the United States","volume":"14","author":"Quock","year":"2025","journal-title":"J Comp Eff Res"},{"issue":"106438","key":"key20251124134831_b67-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.4329\/wjr.v17.i6.106438","article-title":"Factors affecting disease control after pituitary tumor resection in acromegaly: What is the current evidence?","volume":"17","author":"Fernandez","year":"2025","journal-title":"World J Radiol"},{"key":"key20251124134831_b68-MI-5-6-00276","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4161\/cbt.2.6.678","article-title":"Mechanisms by which IGF-I may promote cancer","volume":"2","author":"Grimberg","year":"2003","journal-title":"Cancer Biol Ther"},{"issue":"e220402","key":"key20251124134831_b69-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0402","article-title":"Cancer in growth hormone excess and growth hormone deficit","volume":"30","author":"Guevara-Aguirre","year":"2023","journal-title":"Endocr Relat Cancer"},{"key":"key20251124134831_b70-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11523-017-0514-5","article-title":"Insulin-Like growth factor (IGF) pathway targeting in cancer: Role of the IGF axis and opportunities for future combination studies","volume":"12","author":"Simpson","year":"2017","journal-title":"Target Oncol"},{"issue":"108047","key":"key20251124134831_b71-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.108047","article-title":"The signaling landscape of insulin-like growth factor 1","volume":"301","author":"Khan","year":"2025","journal-title":"J Biol Chem"},{"key":"key20251124134831_b72-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1073\/pnas.1818865116","article-title":"Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma","volume":"116","author":"Villanova","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20251124134831_b73-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11154-024-09929-2","article-title":"The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders","volume":"26","author":"Schally","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"key20251124134831_b74-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"52661","DOI":"10.18632\/oncotarget.11024","article-title":"Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways","volume":"7","author":"Cui","year":"2016","journal-title":"Oncotarget"},{"key":"key20251124134831_b75-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/endocrines5010008","article-title":"Protective activities of growth hormone-releasing hormone antagonists against toxin-induced endothelial injury","volume":"5","author":"Fakir","year":"2024","journal-title":"Endocrines"},{"issue":"2331","key":"key20251124134831_b76-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102331","article-title":"Growth hormone-releasing hormone in lung physiology and pulmonary disease","volume":"9","author":"Zhang","year":"2020","journal-title":"Cells"},{"key":"key20251124134831_b77-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.fertnstert.2009.03.093","article-title":"The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line","volume":"94","author":"Annunziata","year":"2010","journal-title":"Fertil Steril"},{"key":"key20251124134831_b78-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.peptides.2017.01.009","article-title":"Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth","volume":"89","author":"Zarandi","year":"2017","journal-title":"Peptides"},{"key":"key20251124134831_b79-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40618-016-0440-x","article-title":"Peripheral activities of growth hormone-releasing hormone","volume":"39","author":"Granata","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"key20251124134831_b80-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s11154-024-09913-w","article-title":"Growth hormone-releasing hormone in the immune system","volume":"26","author":"Siejka","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"key20251124134831_b81-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1677\/JME-09-0121","article-title":"Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor","volume":"44","author":"Barabutis","year":"2010","journal-title":"J Mol Endocrinol"},{"issue":"bqac209","key":"key20251124134831_b82-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac209","article-title":"Growth hormone-releasing hormone in endothelial inflammation","volume":"164","author":"Barabutis","year":"2022","journal-title":"Endocrinology"},{"key":"key20251124134831_b83-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00018-009-0224-y","article-title":"Activation of Janus kinase\/signal transducer and activator of transcription 3 pathway by growth hormone-releasing hormone","volume":"67","author":"Siejka","year":"2010","journal-title":"Cell Mol Life Sci"},{"issue":"2438974","key":"key20251124134831_b84-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2024.2438974","article-title":"Unfolded protein response modulates the effects of GHRH antagonists in experimental models of in vivo and in vitro lung injury","volume":"13","author":"Fakir","year":"2025","journal-title":"Tissue Barriers"},{"key":"key20251124134831_b85-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/endocrines3040067","article-title":"Growth hormone-releasing hormone antagonist JV-1-36 suppresses reactive oxygen species generation in A549 lung cancer cells","volume":"3","author":"Kubra","year":"2022","journal-title":"Endocrines"},{"key":"key20251124134831_b86-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41574-024-01052-1","article-title":"Growth hormone-releasing hormone and its analogues in health and disease","volume":"21","author":"Granata","year":"2025","journal-title":"Nat Rev Endocrinol"},{"issue":"e22879","key":"key20251124134831_b87-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22879","article-title":"Suppression of reactive oxygen species in endothelial cells by an antagonist of growth hormone-releasing hormone","volume":"35","author":"Akhter","year":"2021","journal-title":"J Biochem Mol Toxicol"},{"key":"key20251124134831_b88-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12672-017-0307-4","article-title":"Inhibitory effects of antagonists of growth hormone-releasing hormone (GHRH) in thyroid cancer","volume":"8","author":"Populo","year":"2017","journal-title":"Horm Cancer"},{"key":"key20251124134831_b89-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1073\/pnas.1120588109","article-title":"Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases","volume":"109","author":"Rick","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20251124134831_b90-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"665","DOI":"10.18632\/oncoscience.92","article-title":"Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study","volume":"1","author":"Perez","year":"2014","journal-title":"Oncoscience"},{"issue":"112554","key":"key20251124134831_b91-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112554","article-title":"Antagonist of growth hormone-releasing hormone MIA-690 attenuates the progression and inhibits growth of colorectal cancer in mice","volume":"146","author":"Recinella","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"key20251124134831_b92-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1073\/pnas.97.2.532","article-title":"Antitumorigenic actions of growth hormone-releasing hormone antagonists","volume":"97","author":"Kineman","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20251124134831_b93-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1073\/pnas.0337496100","article-title":"Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers","volume":"100","author":"Letsch","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"28","key":"key20251124134831_b94-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01043-1","article-title":"c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment","volume":"21","author":"Gao","year":"2023","journal-title":"Cell Commun Signal"},{"key":"key20251124134831_b95-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2010.05.022","article-title":"Growth hormone-releasing hormone antagonist induces apoptosis of human endometrial cancer cells through PKC\u03b4-mediated activation of p53\/p21","volume":"298","author":"Wu","year":"2010","journal-title":"Cancer Lett"},{"key":"key20251124134831_b96-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"14396","DOI":"10.1073\/pnas.1617427113","article-title":"Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells","volume":"113","author":"Chu","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20251124134831_b97-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1073\/pnas.0610860104","article-title":"Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel","volume":"104","author":"Buchholz","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20251124134831_b98-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.peptides.2012.07.010","article-title":"GHRH antagonist inhibits focal adhesion kinase (FAK) and decreases expression of vascular endothelial growth factor (VEGF) in human lung cancer cells in vitro","volume":"37","author":"Siejka","year":"2012","journal-title":"Peptides"},{"key":"key20251124134831_b99-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.4161\/cc.22498","article-title":"GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer","volume":"11","author":"Rick","year":"2012","journal-title":"Cell Cycle"},{"issue":"18","key":"key20251124134831_b100-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-018-0108-5","article-title":"Engineering and monitoring cellular barrier models","volume":"12","author":"Yeste","year":"2018","journal-title":"J Biol Eng"},{"key":"key20251124134831_b101-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pccm.2024.04.002","article-title":"Mechanisms of pulmonary endothelial barrier dysfunction in acute lung injury and acute respiratory distress syndrome","volume":"2","author":"Su","year":"2024","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"key20251124134831_b102-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1097\/PCC.0000000000000431","article-title":"Pathobiology of acute respiratory distress syndrome","volume":"16 (5 Suppl 1)","author":"Sapru","year":"2015","journal-title":"Pediatr Crit Care Med"},{"issue":"1669989","key":"key20251124134831_b103-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2019.1669989","article-title":"GHRH antagonists support lung endothelial barrier function","volume":"7","author":"Uddin","year":"2019","journal-title":"Tissue Barriers"},{"issue":"1231363","key":"key20251124134831_b104-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1231363","article-title":"Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells","volume":"14","author":"Granato","year":"2023","journal-title":"Front Immunol"},{"key":"key20251124134831_b105-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s12020-022-03226-1","article-title":"Protective effects of GHRH antagonists against hydrogen peroxide-induced lung endothelial barrier disruption","volume":"79","author":"Akhter","year":"2023","journal-title":"Endocrine"},{"key":"key20251124134831_b106-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/mi.2008.85","article-title":"Pulmonary fibrosis: Pathogenesis, etiology and regulation","volume":"2","author":"Wilson","year":"2009","journal-title":"Mucosal Immunol"},{"key":"key20251124134831_b107-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"14824","DOI":"10.1074\/jbc.M113.451336","article-title":"Transforming growth factor-\u03b21 (TGF-\u03b21)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts","volume":"288","author":"Midgley","year":"2013","journal-title":"J Biol Chem"},{"key":"key20251124134831_b108-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00408-019-00257-w","article-title":"Growth hormone-releasing hormone receptor antagonist modulates lung inflammation and fibrosis due to bleomycin","volume":"197","author":"Zhang","year":"2019","journal-title":"Lung"},{"issue":"11248","key":"key20251124134831_b109-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911248","article-title":"Antagonist of growth hormone-releasing hormone potentiates the antitumor effect of pemetrexed and cisplatin in pleural mesothelioma","volume":"23","author":"Gesmundo","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"e2308342120","key":"key20251124134831_b110-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2308342120","article-title":"Growth hormone-releasing hormone receptor antagonist MIA-602 attenuates cardiopulmonary injury induced by BSL-2 rVSV-SARS-CoV-2 in hACE2 mice","volume":"120","author":"Condor Capcha","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20251124134831_b111-MI-5-6-00276","author":"Dotiwala"},{"issue":"661838","key":"key20251124134831_b112-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.661838","article-title":"Blood-brain barrier dysfunction amplifies the development of neuroinflammation: Understanding of cellular events in brain microvascular endothelial cells for prevention and treatment of BBB dysfunction","volume":"15","author":"Takata","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"key20251124134831_b113-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","article-title":"The blood-brain barrier in systemic infection and inflammation","volume":"18","author":"Galea","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"key20251124134831_b114-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"12495","DOI":"10.1073\/pnas.0504163102","article-title":"Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: A potential applicability to treatment of brain tumors","volume":"102","author":"Jaeger","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"100009","key":"key20251124134831_b115-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbas.2021.100009","article-title":"Insights on supporting the aging brain microvascular endothelium","volume":"1","author":"Barabutis","year":"2021","journal-title":"Aging Brain"},{"key":"key20251124134831_b116-MI-5-6-00276","author":"O'Toole"},{"key":"key20251124134831_b117-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.tips.2013.10.001","article-title":"Illuminating somatostatin analog action at neuroendocrine tumor receptors","volume":"34","author":"Reubi","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"key20251124134831_b118-MI-5-6-00276","author":"Shahid"},{"key":"key20251124134831_b119-MI-5-6-00276","author":"Olarescu"},{"key":"key20251124134831_b120-MI-5-6-00276","author":"Adigun"},{"issue":"9606985","key":"key20251124134831_b121-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9606985","article-title":"Expression of somatostatin receptor 2 in somatotropinoma correlated with the short-term efficacy of somatostatin analogues","volume":"2017","author":"Liu","year":"2017","journal-title":"Int J Endocrinol"},{"key":"key20251124134831_b122-MI-5-6-00276","author":"Debnath"},{"key":"key20251124134831_b123-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2147\/btt.s3356","article-title":"Therapeutic options in the management of acromegaly: Focus on lanreotide Autogel","volume":"2","author":"Roelfsema","year":"2008","journal-title":"Biologics"},{"key":"key20251124134831_b124-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2042018811434728","article-title":"The efficacy of octreotide LAR in acromegalic patients as primary or secondary therapy","volume":"3","author":"Velija-Asimi","year":"2012","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"e36411","key":"key20251124134831_b125-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036411","article-title":"Meta-analysis on the effects of octreotide on tumor mass in acromegaly","volume":"7","author":"Giustina","year":"2012","journal-title":"PLoS One"},{"key":"key20251124134831_b126-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1677\/erc.1.01191","article-title":"Octreotide promotes apoptosis in human somatotroph tumor cells by activating somatostatin receptor type 2","volume":"13","author":"Ferrante","year":"2006","journal-title":"Endocr Relat Cancer"},{"issue":"1604","key":"key20251124134831_b127-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121604","article-title":"Involvement of ATF6 in octreotide-induced endothelial barrier enhancement","volume":"17","author":"Fakir","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"key20251124134831_b128-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cstres.2024.12.001","article-title":"Ceapin-A7 suppresses the protective effects of Octreotide in human and bovine lung endothelial cells","volume":"30","author":"Fakir","year":"2025","journal-title":"Cell Stress Chaperones"},{"key":"key20251124134831_b129-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1016\/j.apsb.2025.03.043","article-title":"Structural insights into the binding modes of lanreotide and pasireotide with somatostatin receptor 1","volume":"15","author":"Zeng","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"key20251124134831_b130-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/147323001204000213","article-title":"Preoperative lanreotide treatment improves outcome in patients with acromegaly resulting from invasive pituitary macroadenoma","volume":"40","author":"Li","year":"2012","journal-title":"J Int Med Res"},{"key":"key20251124134831_b131-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11102-015-0693-y","article-title":"Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study","volume":"19","author":"Caron","year":"2016","journal-title":"Pituitary"},{"key":"key20251124134831_b132-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/PPA.S20783","article-title":"Lanreotide depot deep subcutaneous injection: A new method of delivery and its associated benefits","volume":"6","author":"Carmichael","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"key20251124134831_b133-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1165\/rcmb.2016-0390OC","article-title":"LPS-induced Acute Lung Injury Involves NF-\u0138B-mediated Downregulation of SOX18","volume":"58","author":"Gross","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"key20251124134831_b134-MI-5-6-00276","author":"Sarker"},{"key":"key20251124134831_b135-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11154-022-09710-3","article-title":"Pasireotide-a novel somatostatin receptor ligand after 20 years of use","volume":"23","author":"Bolanowski","year":"2022","journal-title":"Rev Endocr Metab Disord"},{"key":"key20251124134831_b136-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1677\/ERC-06-0026","article-title":"Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion","volume":"14","author":"Zatelli","year":"2007","journal-title":"Endocr Relat Cancer"},{"issue":"48","key":"key20251124134831_b137-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-025-01514-3","article-title":"Pasireotide as first line medical therapy for selected patients with acromegaly","volume":"28","author":"Olarescu","year":"2025","journal-title":"Pituitary"},{"key":"key20251124134831_b138-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/DDDT.S77999","article-title":"Pasireotide: A novel treatment for patients with acromegaly","volume":"10","author":"Cuevas-Ramos","year":"2016","journal-title":"Drug Des Devel Ther"},{"issue":"1455465","key":"key20251124134831_b139-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1455465","article-title":"Pasireotide-induced hyperglycemia in Cushing's disease and Acromegaly: A clinical perspective and algorithms proposal","volume":"15","author":"Witek","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3000","key":"key20251124134831_b140-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14093000","article-title":"Clinical implications of molecular and genetic biomarkers in Cushing's disease: A literature review","volume":"14","author":"Chinezu","year":"2025","journal-title":"J Clin Med"},{"issue":"942","key":"key20251124134831_b141-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/ph18070942","article-title":"Protective effects of pasireotide in LPS-induced acute lung injury","volume":"18","author":"Fakir","year":"2025","journal-title":"Pharmaceuticals (Basel)"},{"key":"key20251124134831_b142-MI-5-6-00276","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s12020-024-03741-3","article-title":"Pharmacokinetics and pharmacodynamics of a pasireotide subcutaneous depot (CAM4071) and comparison with immediate and long-acting release pasireotide","volume":"84","author":"Johnsson","year":"2024","journal-title":"Endocrine"},{"issue":"1682","key":"key20251124134831_b143-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051682","article-title":"Somatostatin analogs in clinical practice: A review","volume":"21","author":"Gomes-Porras","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6079","key":"key20251124134831_b144-MI-5-6-00276","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13206079","article-title":"A 2024 update on growth hormone deficiency syndrome in adults: From guidelines to real life","volume":"13","author":"Aversa","year":"2024","journal-title":"J Clin Med"}],"container-title":["Medicine International"],"original-title":[],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:48:38Z","timestamp":1763984918000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mi.2025.276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":144,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,10,22]]}},"URL":"https:\/\/doi.org\/10.3892\/mi.2025.276","relation":{},"ISSN":["2754-3242","2754-1304"],"issn-type":[{"value":"2754-3242","type":"print"},{"value":"2754-1304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}